C5AR1 and Gaucher disease: A recent study demonstrated that C5aR1 regulates glucosylceramide cellular accumulation in experimental and clinical Gaucher disease, which induces complement-activating IgG autoantibodies that drive C5a generation and C5aR1 activation, feeding a cycle of glucosylceramide accumulation and immune response activation [83].